AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05352282 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lumbar Intrathecal Fentanyl Injection
Description: Patients will receive 25 microgram intracthecal fentanyl immediately preoperative.
Study NCT05144464 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Quadrivalent influenza vaccine
Description: Subjects receive two doses of quadrivalent influenza vaccine administered 4 weeks apart by intramuscular injection
Study NCT06384482 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SNC115 injection
Description: SNC115 Injection is DLL3 CART.
Study NCT05443919 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TwiFlow-Thrombectomy Catheter System
Description: Patients with acute pulmonary embolism and meeting the conditions of this clinical trial will accept the pulmonary embolism removal operation by the novel device named 'TwiFlow-Thrombectomy Catheter System'.
Study NCT02107222 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CO2-Removal (PALP-Device/MaquetCP)
Description: extracorporeal circuit to remove CO2 out of the blood
Study NCT04775069 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: BNT162b2
Description: Intramuscular injection
Study NCT04775069 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: CoronaVac
Description: Intramuscular injection
Study NCT04775069 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AZD1222
Description: Intramuscular injection
Study NCT05699746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine tablets
Description: Capecitabine 1000 mg/m2, twice daily PO for 14 days, repeat every 3 weeks, for at most 8 cycles.
Study NCT05699746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Oxaliplatin 130 mg/m2 IV day 1, combined with Capecitabine, for at most 8 cycles.
Study NCT04741542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SP-420
Description: This study aims to establish the safety of SP-420 administered orally three times per week (TIW).
Study NCT06442592 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Blood sampling
Description: An EDTA blood sample will be taken from the children and their two parents. Sample volume will be 2 x 3mL.
Study NCT05902741 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RiSE
Description: RiSE provides participants with a platform to share the emotional impact of race-based stress and to offer supportive listening to their peers. Participants explicitly discuss the experiences they have as African American women, taking into account the ways which the interaction between their racial and gender identities shapes their experiences. Facilitators review difficulties associated with addressing racism and unique experiences of Black women at interpersonal and structural levels, and provide evidence of strategies to promote effective communication and internal emotional regulation regarding experiences of racism. Facilitators provide psychoeducation on intersectionality, structural racism, overt racism, microaggressions, and internalized racism. Following this education, facilitators help participants utilize cognitive-behavioral strategies to understand consequent thoughts, feelings, and actions associated with such experiences.
Study NCT05902741 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: HEP
Description: The HEP group will consist of classes focusing on wellness promotion. Expert speakers provide the HEP classes (e.g dietician, pharmacist).
Study NCT04987814 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HD-sEMG
Description: high definition surface electromyography, allowing the recording of muscle activation signals sensitive to the intensity of the contraction and indirectly to the muscle strength as well as to the muscular fatigability, but also capable of measuring the modifications of the recruitment modalities of the motor units. This recording will be made on the rectus femoris during knee extension, either in the lying position or during chair lifts, depending on the patient's functional state.
Study NCT04987814 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: - Quadriceps muscle ultrasound
Description: Muscle Ultrasound with Philips Lumify Wireless Handheld Ultrasound for Android - Model - L12-4 linear probe, allowing performance at the patient's bed.
Study NCT04987814 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IPAQ Physical Activity Questionnaire.
Description: physical activity assessment questionnaire/adapted version for seniors
Study NCT04925661 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC53856
Description: Either dose of HEC53856 will be administered after fasting .
Study NCT06639646 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotics supplements
Description: A Dietary intervention group receiving health education message about healthy diet and probiotics supplements ( spores of poly antibiotic resistant Lactobacilli 5 billion in form of capsules registrated by the Egyption drug auyjority EDA and sold in Egyption markets under brand name Lactèol Forte ® capsules by Rameda® company.~The probiotic supplement is recommended to be given twice daily for 12 wks duration.
Study NCT06639646 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Health diet
Description: A Control group receiving health education about healthy diet. At the end of the 12 wk. period, the same measurements are repeated
Study NCT06637930 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Edentulous Alveolar Ridge In Mandible
Description: implant retained mandibular overdenture using telescopic attachment system. all the patients received 2 implants at the canine region bilaterally using sterelithographic guide , then healing period for 3 months for proper osseointegration , then digital intraoral scanning was performed to detect implant position using scannable bodies , abutments which act as primary crowns were designed on cad software then milled using premilled titanium abutments.the study grouping was performed then virtual model was done for the designing of the frameworks then milled according to the grouping of the study. Try in of the frameworks was done and overdentures were inserted.~* Retention force test was done using digital force gauge.~* Probing depth using Teflon coated periodontal probe.~* Marginal bone level and bone density were measured using digital periapical x-ray
Study NCT06640738 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: arm 2
Description: This study tries to find the best drug concentration of Remifentanil, ALVOGEN® (2 mg/vial) in Uterine Fibroid Ablation. We have two arms. Arm 1 with Remifentanil, ALVOGEN® (2 mg/vial) 1.0 ng/mL, and arm 2 with Remifentanil, ALVOGEN® (2 mg/vial) 2.0 ng/mL, both given via a syringe infusion pump, Perfusor® Space \| B. Braun.
Study NCT06640738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: arm 1
Description: This study tries to find the best drug concentration of Remifentanil, ALVOGEN® (2 mg/vial) in Uterine Fibroid Ablation. We have two arms. Arm 1 with Remifentanil, ALVOGEN® (2 mg/vial) 1.0 ng/mL, and arm 2 with Remifentanil, ALVOGEN® (2 mg/vial) 2.0 ng/mL, both given via a syringe infusion pump, Perfusor® Space \| B. Braun.
Study NCT06640140 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supervised aerobic plus strength training
Description: Supervised moderate to high-intensity interval aerobic training plus moderate to high-intensity strength training.
Study NCT05730335 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rapid Acoustic Pulse
Description: Transdermal Rapid Acoustic Pulse Treatments
Study NCT06642415 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgery under loupes
Description: surgery performed under loupes
Study NCT06642415 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery under loupes
Description: surgery performed under loupes
Study NCT06642415 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: surgery performed under microscope
Description: surgery performed under microscope
Study NCT06642415 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: surgery performed under microscope
Description: surgery performed under microscope
Study NCT06257485 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 99mTc-pyrophosphate Single Photon Emission Computed Tomography
Description: All patients underwent 99mTc-pyrophosphate Single Photon Emission Computed Tomography and had a baseline echocardiogram
Study NCT05593289 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: telerehabilitation
Description: Physical activity that is planned, structured with repeated muscle movements with the aim of relearning motor skills, resistance of neck muscles and postural correction.
Study NCT06632171 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy- Based and Motivational Interviewing-Supported Psychoeducation
Description: The aim of this study is to examine the effects of cognitive-behavioral-based and motivational interview-supported psychoeducation on emotional eating and psychological resilience in obese individuals. The study will be conducted in a randomized controlled experimental design. The sample of the study will consist of 102 obese individuals in total, 51 in the experimental group and 51 in the control group, who meet the inclusion criteria. A cognitive-behavioral and motivational interview-supported psychoeducation program will be applied to the experimental group. All patients will be evaluated at three time points: pretest (baseline), posttest (8 weeks), and follow-up test (3 months after the posttest). No intervention will be applied to the control group.
Study NCT05338307 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: R-1,3-Butanediol
Description: Study participants will be taking 35mL of HVMN Ketone-IQ by mouth three times daily, with each dose containing 10 grams of R-1,3-Butanediol.
Study NCT04995341 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Investigational ultracompact OCT and OCTA system
Description: Handheld bedside retinal OCT and OCT angiography imaging with an investigational portable system with ultracompact handpiece
Study NCT05639699 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: motivational interview
Description: Quitting smoking with motivational interviewing
Study NCT05449002 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Practicing the Opposite (PTO)
Description: This 30-45-minute digital program is designed to help youths on the waitlist feel better prior to treatment and may also improve their treatment engagement and outcomes.
Study NCT05449002 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Clinical Care
Description: Usual care provided by participating youth mental health clinics in the United States.
Study NCT05461547 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lung Ultrasound
Description: LUS will be performed and interpreted in real-time to guide acute management.
Study NCT04995341 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: retinal photographs
Description: retinal photographs with a commercial portable bedside widefield fundus camera system
Study NCT05461547 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: Usual care to decide diagnosis and treatment
Study NCT06442592 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Assessment of neurodevelopment (CA)
Description: The children will be seen by a neuropsychologist, who will then determine whether or not they have neurodevelopmental disorders.
Study NCT06442592 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Assessment of neurodevelopment (Nantes)
Description: The children will be seen by a multidisciplinary team (including a neuropsychologist), who will then determine whether or not they have neurodevelopmental disorders.
Study NCT06442592 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Assessment of the parental stress
Description: Parents' parental stress will be assessed using the Parental Stress Index (PSI) questionnaire.
Study NCT05345327 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: SGLT2 inhibitor
Study NCT05345327 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: Metformin
Study NCT05657106 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Harm reduction kiosk
Description: The intervention involves enhancing an existing staffed harm reduction program (syringe service program) located in a local health department with a Kentucky Outreach Service Kiosk (KyOSK).
Study NCT04963608 — intervention group
Intervention type: DRUG
Intervention: Inetetamab
Description: 8mg/kg iv day 1 followed by 6mg/kg iv day 1, cycled every 21 days
Study NCT06316674 — intervention group
Intervention type: BEHAVIORAL
Intervention: sixth finger illusion
Description: Participants will undertake the sixth finger illusion that is a body illusion which elicits the presence of an extra numerary finger due to visuo-tactile stimulation.
Study NCT04858425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niclosamide
Description: Niclosamide tablets 400 mg 3 times daily for 14 days
Study NCT04858425 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo tablets 400 mg 3 times daily for 14 days
Study NCT06239688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: essentiALZ
Description: essentiALZ is a web-based training that contains three hours of self-paced content separated into five modules, plus a final review. Modules include: 1) Alzheimer's disease and dementia; 2) person-centered care; 3) assessment and care planning; 4) activities of daily living; and 5) behaviors and communication. Staff will be encouraged to take the training over the course of four weeks.
Study NCT06239688 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project ECHO
Description: ECHO is a virtual tele-mentoring model grounded in case-based learning. It includes six weekly one-hour sessions of didactic and discussive learning. The first five sessions will reflect the content of the five essentiALZ modules, and the final session will address maintenance. ECHO sessions are group sessions that will be conducted via Zoom.
Study NCT06474299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Varenicline
Description: 0.5 mg pill once a day for the first 3 days and then increase to a 0.5 mg pill twice a day (at least 8 hours apart) for 4 days prior to the TQD. On the 8th day (the TQD), participants will increase to their target maintenance dose of a 1 mg pill twice daily
Study NCT06474299 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotine patch
Description: Following package inserts starting on the TQD, participants who smoke >10 cigarettes per day at baseline will be given 8 weeks of 21 mg nicotine patches, followed by 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Participants who smoke ≤10 cigarettes per day at baseline will be given 10 weeks of 14 mg nicotine patches followed by 2 weeks of 7 mg patches.
Study NCT06474299 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dual Focused Cessation Counseling
Description: Dual Focused Cessation Counseling will focus on quitting both smoking and vaping. Specifically, participants will be instructed to change smoking and vaping patterns (e.g., not smoking or vaping in specific places such as the car or at specific times of day) prior to quitting and to practice cessation coping strategies (e.g., distraction techniques, getting social support).
Study NCT06474299 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smoking Focused Cessation Counseling
Description: Smoking Focused Cessation Counseling will focus on quitting smoking and using ENDS as a harm reduction strategy (i.e., using ENDS as a substitute for cigarettes).
Study NCT06474299 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Counseling Intensity: 1 Session
Description: Participants assigned to one session will complete a single, 15-20 minute, in-person session at Visit 2 (1 week pre-TQD).
Study NCT06474299 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Counseling Intensity: 4 Sessions
Description: Participants assigned to intensive counseling will have four, 15-20-minute sessions, one in-person at Visit 2 and then 3 phone sessions: 1 day post-TQD and Weeks 1 and 2.
Study NCT06369506 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: GTmeasurement
Description: GT was measured from the point corresponding to the base of the gingival sulcus and 1 mm and 2 mm apical to this point. If the GT was ≤1 mm, it was considered a thin phenotype, and if it was >1 mm, it was considered a thick phenotype.
Study NCT05785806 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Skin to skin contact and co-parenting theory course
Description: On the day before delivery, pregnant women and their husbands attend a course on the theory of skin contact and co-parenting to explain the role and importance of skin contact ; to understand the knowledge of co-parenting and parenting care ; to learn the communication method and future parenting plan based on the theory of co-parenting, and to learn the operation of skin contact with newborns after delivery.
Study NCT05785806 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Skin to skin contact instruction manual and co-parenting theory brochure
Description: According to reading and analyzing the literature on skin contact, summarize the content of skin contact operation guidance ; read and analyze the relevant literature of co-parenting theory, and summarize the theoretical knowledge and practical operation methods of co-parenting. Pregnant women and their spouses can check in time.
Study NCT05785806 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Daily face-to-face skin to skin contact guidance during hospitalization
Description: After delivery, face-to-face skin-to-skin contact guidance and co-parenting communication and practice were given to the parturient and her husband on a daily basis during hospitalization. Establish a daily fixed skin contact duration target, and the specific operation is freely allocated by both parents.
Study NCT05785806 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online punching skin to skin contact
Description: Share common parenting related knowledge, daily skin contact reminders, emphasize mutual recognition and mutual support of parents, and conduct WeChat follow-up every two weeks to understand the physical and mental status of both parties and the growth of infants.
Study NCT05785806 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Routine obstetric care
Description: Routine prenatal training and postpartum education, including basic breastfeeding guidelines, touching, etc.
Study NCT06507618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen, Letrozole, Anastrozole, or Exemestane
Description: Choice and dose of neoadjuvant endocrine therapy at the discretion of the treating medical oncologist.
Study NCT04925661 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Roxadustat
Description: Roxadustat will be administered after fasting .
Study NCT04925661 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Either dose of placebo will be administered after fasting .
Study NCT06563908 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lipiodol® uterine treatment prior to IVF/ICSI
Description: Lipiodol®, treatment will be performed by a HSG technique with X-ray screening on day 3 or day 5 after oocyte retrieval. The contrast medium will be Lipiodol Ultra Fluide® (Guerbet, France), an iodized poppy seed oil obtained by substitution of ethyl esters for the glyceryl esters of Lipiodol®. One millilitre of Lipiodol Ultra Fluide® contains 0.48g iodine. Women will lie in the left lateral or supine position. Radiologists will use a 'no touch' technique after applying antiseptic solution to the cervix. Uterine cannulation using the Cook HSG catheter will be applied to conduct Lipiodol® treatment. Prewarmed (37oC) Lipiodol® will be slowly instilled, with intermittent fluoroscopic X-ray guidance. Up to 10 ml of Lipiodol® will be slowly injected into the uterus and directly monitored by fluoroscopy. If intravasation was observed on X-ray (contrast apparent in the venous system), instillation will be stopped immediately.
Study NCT06029790 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: gum chewing
Description: For the patients in the experimental group, sugar-free xylitol gum containing 1.2-1.37 grams of xylitol per piece, available in the market, will be used. Participants in the experimental group will start chewing gum on the first postoperative day and will be allowed to chew a single piece of gum 3 times a day at 9:00, 14:00 and 19:00, respectively, for 15 minutes. The gum will be given to the participants regularly by a researcher until the first reported flatulence.
Study NCT06467968 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cardiac ECG-gated PET imaging will added
Description: Blood sample will be used to measure troponin, BNP and CRP . After 68Ga-DOTATOC PET/CT whole body recording, a cardiac ECG-gated PET imaging will added
Study NCT05866081 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard of care stent placement
Description: Participants will have a stent placed per randomization assigned if there are no complications (per protocol) during ureteroscopy that excludes the participant.
Study NCT05866081 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No stent placement
Description: Participants not have a stent placed per randomization assigned if there are no complications (per protocol) during ureteroscopy that excludes the participant.